Akebia Therapeutics (AKBA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AKBA | VRCA | EPIX | ||
| Company | Akebia Therapeutics | Verrica Pharmaceuticals Inc | Essa Pharma | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 1.3700 | 6.81 | 6.47 | ||
| High | 1.4000 | 6.86 | 6.57 | ||
| Low | 1.3600 | 6.65 | 6.38 | ||
| Last | 1.3600 | 6.75 | 6.40 | ||
| Change | -0.0100 | -0.10 | unch | ||
| % Change | -0.73% | -1.46% | unch | ||
| Volume | 574,084 | 47,824 | 10,013 | ||
| 20-Day Average Volume | 7,678,172 | 171,086 | 63,387 | ||
| Previous Close | 1.3700 | 6.85 | 6.40 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 1.5215 | 6.66 | 7.62 | ||
| 20-Day Raw Stochastic | 5.98% | 74.51% | 12.79% | ||
| 20-Day Relative Strength | 42.95% | 60.94% | 35.37% | ||
| Weighted Alpha | +17.62 | +1.47 | -5.16 | ||
| Today's Opinion | 24% Buy | 100% Buy | 8% Sell | ||
| Previous Opinion | 24% Buy | 100% Buy | 8% Sell | ||
| Last Month's Opinion | 100% Buy | 40% Buy | 80% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.72% since 04/17/24 | -3.68% since 04/17/24 | -7.14% since 04/17/24 | ||
| Low | 1.3100 on 04/19/24 | 6.57 on 04/22/24 | 6.18 on 04/19/24 | ||
| High | 1.4350 on 04/18/24 | 7.06 on 04/18/24 | 7.30 on 04/18/24 | ||
| 1-Month | |||||
| %Chg | -36.41% since 03/22/24 | +35.73% since 03/22/24 | -27.30% since 03/22/24 | ||
| Low | 1.3100 on 04/19/24 | 4.78 on 03/26/24 | 6.18 on 04/19/24 | ||
| High | 2.4800 on 03/28/24 | 7.32 on 04/10/24 | 9.23 on 03/26/24 | ||
| 3-Month | |||||
| %Chg | -6.12% since 01/24/24 | +24.77% since 01/24/24 | -25.31% since 01/24/24 | ||
| Low | 1.3100 on 04/19/24 | 4.60 on 03/20/24 | 6.18 on 04/19/24 | ||
| High | 2.4800 on 03/28/24 | 7.32 on 04/10/24 | 11.67 on 02/07/24 | ||
| 6-Month | |||||
| %Chg | +61.03% since 10/24/23 | +84.78% since 10/24/23 | +68.33% since 10/24/23 | ||
| Low | 0.7801 on 10/26/23 | 2.86 on 11/14/23 | 3.89 on 10/26/23 | ||
| High | 2.4800 on 03/28/24 | 7.51 on 12/27/23 | 11.67 on 02/07/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 286,840 | 290,577 | 283,136 | ||
| Shares Outstanding, K | 209,372 | 42,420 | 44,240 | ||
| Annual Sales | 194,620,000 | 5,120,000 | 0 | ||
| Annual Net Income | -51,930,000 | -67,000,000 | -26,580,000 | ||
| Last Quarter Sales | 56,070,000 | 1,990,000 | 0 | ||
| Last Quarter Net Income | -50,000 | -24,610,000 | -5,960,000 | ||
| 60-Month Beta | 0.79 | 1.88 | 1.62 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.00 on 03/14/24 | -0.48 on 02/29/24 | -0.14 on 02/13/24 | ||
| Latest Earnings Date | 05/13/24 | 05/14/24 | 05/14/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||